2021
DOI: 10.1016/j.jpba.2020.113853
|View full text |Cite
|
Sign up to set email alerts
|

Separation and characterization of impurity P in azithromycin product

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…The analyses show all mixture components and are nearly free of any background ions; the m / z 591 is tentatively assigned as fragment ion of azithromycin. 89 For some drugs and thermometer molecules, there has been some tendency of low-intensity fragmentation by vMAI, despite that no energy is added (laser, heat, voltages) to promote analyte ionization. 90,91 The analyses of urine are also straightforward.…”
Section: Resultsmentioning
confidence: 99%
“…The analyses show all mixture components and are nearly free of any background ions; the m / z 591 is tentatively assigned as fragment ion of azithromycin. 89 For some drugs and thermometer molecules, there has been some tendency of low-intensity fragmentation by vMAI, despite that no energy is added (laser, heat, voltages) to promote analyte ionization. 90,91 The analyses of urine are also straightforward.…”
Section: Resultsmentioning
confidence: 99%
“…An important factor for the safety and effectiveness of pharmaceuticals is the purity of the drug, making impurity profiling critical [7,8]. Various unknown impurities could form in the drug product during formulation, manufacturing, and storage as well as in the synthesis of the active pharmaceutical ingredient (API) [9].…”
Section: Introductionmentioning
confidence: 99%